HUP9902405A3 - Pharmaceutical compositions containing a serotonin antagonist for the treatment of the common cold or allergic rhinitis - Google Patents
Pharmaceutical compositions containing a serotonin antagonist for the treatment of the common cold or allergic rhinitisInfo
- Publication number
- HUP9902405A3 HUP9902405A3 HU9902405A HUP9902405A HUP9902405A3 HU P9902405 A3 HUP9902405 A3 HU P9902405A3 HU 9902405 A HU9902405 A HU 9902405A HU P9902405 A HUP9902405 A HU P9902405A HU P9902405 A3 HUP9902405 A3 HU P9902405A3
- Authority
- HU
- Hungary
- Prior art keywords
- treatment
- pharmaceutical compositions
- compositions containing
- allergic rhinitis
- common cold
- Prior art date
Links
- 206010039085 Rhinitis allergic Diseases 0.000 title 1
- 201000010105 allergic rhinitis Diseases 0.000 title 1
- 239000003420 antiserotonin agent Substances 0.000 title 1
- 201000009240 nasopharyngitis Diseases 0.000 title 1
- 239000008194 pharmaceutical composition Substances 0.000 title 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
- C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
- C07D401/12—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a chain containing hetero atoms as chain links
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
- A61K31/445—Non condensed piperidines, e.g. piperocaine
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
- A61K31/445—Non condensed piperidines, e.g. piperocaine
- A61K31/4523—Non condensed piperidines, e.g. piperocaine containing further heterocyclic ring systems
- A61K31/454—Non condensed piperidines, e.g. piperocaine containing further heterocyclic ring systems containing a five-membered ring with nitrogen as a ring hetero atom, e.g. pimozide, domperidone
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
- A61P11/02—Nasal agents, e.g. decongestants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P27/00—Drugs for disorders of the senses
- A61P27/16—Otologicals
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D209/00—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom
- C07D209/02—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom condensed with one carbocyclic ring
- C07D209/04—Indoles; Hydrogenated indoles
- C07D209/10—Indoles; Hydrogenated indoles with substituted hydrocarbon radicals attached to carbon atoms of the hetero ring
- C07D209/14—Radicals substituted by nitrogen atoms, not forming part of a nitro radical
- C07D209/16—Tryptamines
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D209/00—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom
- C07D209/56—Ring systems containing three or more rings
- C07D209/80—[b, c]- or [b, d]-condensed
- C07D209/82—Carbazoles; Hydrogenated carbazoles
- C07D209/88—Carbazoles; Hydrogenated carbazoles with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to carbon atoms of the ring system
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D209/00—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom
- C07D209/56—Ring systems containing three or more rings
- C07D209/80—[b, c]- or [b, d]-condensed
- C07D209/94—[b, c]- or [b, d]-condensed containing carbocyclic rings other than six-membered
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
- C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
- C07D401/04—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings directly linked by a ring-member-to-ring-member bond
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
- C07D401/14—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing three or more hetero rings
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D403/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00
- C07D403/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings
- C07D403/12—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings linked by a chain containing hetero atoms as chain links
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
- C07D405/02—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings
- C07D405/12—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings linked by a chain containing hetero atoms as chain links
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
- C07D405/14—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing three or more hetero rings
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D409/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms
- C07D409/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings
- C07D409/12—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings linked by a chain containing hetero atoms as chain links
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D409/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms
- C07D409/14—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing three or more hetero rings
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D413/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
- C07D413/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings
- C07D413/12—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings linked by a chain containing hetero atoms as chain links
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D413/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
- C07D413/14—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing three or more hetero rings
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Veterinary Medicine (AREA)
- Pharmacology & Pharmacy (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Animal Behavior & Ethology (AREA)
- Life Sciences & Earth Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Bioinformatics & Cheminformatics (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Engineering & Computer Science (AREA)
- Epidemiology (AREA)
- Pulmonology (AREA)
- Immunology (AREA)
- Otolaryngology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Plural Heterocyclic Compounds (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US2409696P | 1996-08-16 | 1996-08-16 |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| HUP9902405A2 HUP9902405A2 (hu) | 2000-04-28 |
| HUP9902405A3 true HUP9902405A3 (en) | 2002-11-28 |
Family
ID=21818851
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| HU9902405A HUP9902405A3 (en) | 1996-08-16 | 1997-08-12 | Pharmaceutical compositions containing a serotonin antagonist for the treatment of the common cold or allergic rhinitis |
Country Status (17)
| Country | Link |
|---|---|
| US (1) | US5962473A (hu) |
| EP (1) | EP0824917A3 (hu) |
| JP (1) | JP2000516233A (hu) |
| KR (1) | KR20000035789A (hu) |
| CN (1) | CN1233180A (hu) |
| AU (1) | AU716904B2 (hu) |
| BR (1) | BR9711147A (hu) |
| CA (1) | CA2263550A1 (hu) |
| CZ (1) | CZ289998B6 (hu) |
| EA (1) | EA001740B1 (hu) |
| HU (1) | HUP9902405A3 (hu) |
| IL (1) | IL128379A0 (hu) |
| NO (1) | NO990701L (hu) |
| NZ (1) | NZ334029A (hu) |
| PL (1) | PL331708A1 (hu) |
| WO (1) | WO1998006402A1 (hu) |
| YU (1) | YU7699A (hu) |
Families Citing this family (23)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO2000063171A1 (fr) | 1999-04-20 | 2000-10-26 | Meiji Seika Kaisha, Ltd. | Composes tricycliques |
| EP1242072A4 (en) | 1999-12-17 | 2004-02-04 | Bristol Myers Squibb Co | ANTIPSYCHOTIC HETEROCYCLIC COMPOUNDS |
| CA2433100A1 (en) | 2000-12-27 | 2002-07-04 | Helmut Haning | Indole derivatives as ligands of thyroid receptors |
| US8048917B2 (en) | 2005-04-06 | 2011-11-01 | Xenoport, Inc. | Prodrugs of GABA analogs, compositions and uses thereof |
| US7186855B2 (en) | 2001-06-11 | 2007-03-06 | Xenoport, Inc. | Prodrugs of GABA analogs, compositions and uses thereof |
| US6818787B2 (en) | 2001-06-11 | 2004-11-16 | Xenoport, Inc. | Prodrugs of GABA analogs, compositions and uses thereof |
| ES2296956T5 (es) | 2001-06-11 | 2011-07-12 | Xenoport, Inc. | Profármacos de análogos de gaba, composiciones y sus usos. |
| ES2187300B1 (es) * | 2001-11-14 | 2004-06-16 | Laboratorios Del Dr. Esteve, S.A. | Derivados de sulfonamidas, su preparacion y su aplicacion como medicamentos. |
| AU2002351412B2 (en) | 2001-12-21 | 2010-05-20 | Exelixis Patent Company Llc | Modulators of LXR |
| US7482366B2 (en) | 2001-12-21 | 2009-01-27 | X-Ceptor Therapeutics, Inc. | Modulators of LXR |
| DE10217006A1 (de) * | 2002-04-16 | 2003-11-06 | Merck Patent Gmbh | Substituierte Indole |
| JP4825679B2 (ja) | 2003-11-17 | 2011-11-30 | ベーリンガー インゲルハイム インターナショナル ゲゼルシャフト ミット ベシュレンクテル ハフツング | 新規ピペリジン置換インドール又はこれらのヘテロ誘導体 |
| BRPI0517227B8 (pt) | 2004-11-04 | 2021-05-25 | Xenoport Inc | comprimido oral de liberação prolongada do ácido 1-{[alfa-isobutanoiloxietoxi)carbonil]amino metil}-1-cicloexano acético, e, uso do comprimido |
| ATE531706T1 (de) * | 2005-04-30 | 2011-11-15 | Boehringer Ingelheim Int | Neue piperidin-substituierte indole und ihre verwendung als ccr-3-modulatoren |
| CA2667547C (en) | 2006-10-27 | 2014-07-29 | Boehringer Ingelheim International Gmbh | Piperidyl-propane-thiol ccr3 modulators |
| US9199918B2 (en) | 2011-02-15 | 2015-12-01 | Georgetown University | Small molecule inhibitors of AGBL2 |
| ES2685839T3 (es) * | 2013-08-02 | 2018-10-11 | Pfizer Inc. | Inhibidores de RORC2 heterobicicloarilo y procedimientos de uso de los mismos |
| EP3250570A1 (en) | 2015-01-30 | 2017-12-06 | Pfizer Inc | Methoxy-substituted pyrrolopyridine modulators of rorc2 and methods of use thereof |
| WO2016120850A1 (en) | 2015-01-30 | 2016-08-04 | Pfizer Inc. | Sulfonamide-subsituted indole modulators of rorc2 and methods of use thereof |
| CN106045967B (zh) * | 2015-04-08 | 2020-04-21 | 广东东阳光药业有限公司 | 取代杂环化合物及其在药物上的应用 |
| CN106045966B (zh) * | 2015-04-08 | 2020-04-21 | 广东东阳光药业有限公司 | 取代杂环化合物及其在药物上的应用 |
| CN110831600B (zh) | 2017-04-21 | 2023-10-17 | 医肯纳肿瘤学公司 | 吲哚ahr抑制剂和其用途 |
| CN115784911A (zh) * | 2022-10-19 | 2023-03-14 | 山东省药学科学院 | 一种1-[2-(4-氯苯基)-乙基氨基]-2-丙醇的合成方法 |
Family Cites Families (8)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US4443451A (en) * | 1981-07-15 | 1984-04-17 | Janssen Pharmaceutica N.V. | Bicyclic pyrimidin-5-one derivatives |
| GB9125699D0 (en) * | 1991-12-03 | 1992-01-29 | Glaxo Group Ltd | Device |
| US5698571A (en) * | 1994-10-05 | 1997-12-16 | Eli Lilly And Company | 5-HT1F mediated inhibition of neurogenic meningeal extravasation: a method for the treatment of migraine |
| US5521196A (en) * | 1994-10-05 | 1996-05-28 | Eli Lilly And Company | 5-HT1F agonists for the treatment of migraine |
| US5521197A (en) * | 1994-12-01 | 1996-05-28 | Eli Lilly And Company | 3-<1-alkylenearyl>-4-<1,2,3,6-tetrahydropyridinyl>-and 3-<1-alkylenearyl>-4-piperidinyl-1h-indoles: new 5-HT1F agonists |
| PL322843A1 (en) * | 1995-03-20 | 1998-02-16 | Lilly Co Eli | 5-substituted 3-91,2,3,6-tetrahydropyridin-4-yl)- and 3-9piperydin-4-4-yl0-1h-indoles nevel 5-htif natagonists |
| AU5966196A (en) * | 1995-06-08 | 1997-01-09 | Eli Lilly And Company | Methods of treating cold and allergic rhinitis |
| US5942536A (en) * | 1995-10-10 | 1999-08-24 | Eli Lilly And Company | N- 2-substituted-3-(2-aminoethyl)-1H-indol-5-YL!-Amides: new 5-HT1F agonists |
-
1997
- 1997-08-05 US US08/906,770 patent/US5962473A/en not_active Expired - Fee Related
- 1997-08-12 IL IL12837997A patent/IL128379A0/xx unknown
- 1997-08-12 NZ NZ334029A patent/NZ334029A/xx unknown
- 1997-08-12 KR KR1019997001285A patent/KR20000035789A/ko not_active Application Discontinuation
- 1997-08-12 WO PCT/US1997/014097 patent/WO1998006402A1/en not_active Application Discontinuation
- 1997-08-12 CA CA002263550A patent/CA2263550A1/en not_active Abandoned
- 1997-08-12 CZ CZ1999440A patent/CZ289998B6/cs not_active IP Right Cessation
- 1997-08-12 AU AU40615/97A patent/AU716904B2/en not_active Ceased
- 1997-08-12 HU HU9902405A patent/HUP9902405A3/hu unknown
- 1997-08-12 BR BR9711147A patent/BR9711147A/pt unknown
- 1997-08-12 YU YU7699A patent/YU7699A/sh unknown
- 1997-08-12 EP EP97306130A patent/EP0824917A3/en not_active Withdrawn
- 1997-08-12 JP JP10509943A patent/JP2000516233A/ja active Pending
- 1997-08-12 CN CN97198718A patent/CN1233180A/zh active Pending
- 1997-08-12 PL PL97331708A patent/PL331708A1/xx unknown
- 1997-08-12 EA EA199900206A patent/EA001740B1/ru not_active IP Right Cessation
-
1999
- 1999-02-15 NO NO990701A patent/NO990701L/no not_active Application Discontinuation
Also Published As
| Publication number | Publication date |
|---|---|
| CN1233180A (zh) | 1999-10-27 |
| NO990701D0 (no) | 1999-02-15 |
| CZ289998B6 (cs) | 2002-05-15 |
| CA2263550A1 (en) | 1998-02-19 |
| HUP9902405A2 (hu) | 2000-04-28 |
| EP0824917A3 (en) | 2000-08-30 |
| KR20000035789A (ko) | 2000-06-26 |
| EP0824917A2 (en) | 1998-02-25 |
| US5962473A (en) | 1999-10-05 |
| AU716904B2 (en) | 2000-03-09 |
| PL331708A1 (en) | 1999-08-02 |
| EA199900206A1 (ru) | 1999-08-26 |
| YU7699A (sh) | 2001-09-28 |
| BR9711147A (pt) | 1999-08-17 |
| NO990701L (no) | 1999-04-16 |
| JP2000516233A (ja) | 2000-12-05 |
| EA001740B1 (ru) | 2001-08-27 |
| CZ44099A3 (cs) | 1999-10-13 |
| NZ334029A (en) | 2000-07-28 |
| IL128379A0 (en) | 2000-01-31 |
| WO1998006402A1 (en) | 1998-02-19 |
| AU4061597A (en) | 1998-03-06 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| HUP9902405A3 (en) | Pharmaceutical compositions containing a serotonin antagonist for the treatment of the common cold or allergic rhinitis | |
| IL125735A0 (en) | Pharmaceutical compositions for the treatment of glaucoma | |
| HUP0103856A3 (en) | Pharmaceutical composition for the treatment of acute disorders | |
| HUP0104676A2 (en) | Compositions for the treatment of anorectal disorders and their use | |
| IL122345A0 (en) | Benzamide derivatives their use as vasopressin antagonists processes for the preparation thereof and pharmaceutical compositions containing the same | |
| IL135800A0 (en) | Methods and pharmaceutical compositions for the closure of retinal breaks | |
| IL147217A0 (en) | New spirooxindole derivatives and pharmaceutical compositions containing the same for treatment of pain | |
| IL122733A0 (en) | Pharmaceutical compositions for use in the treatment of allergic asthma | |
| HUP0001267A3 (en) | Use of rapamycin derivatives for the preparation of pharmaceutical compositions treating vasculopathies | |
| GB2311940B (en) | Pharmaceutical compositions for the treatment of rhinitis | |
| HUP0003851A3 (en) | Pharmaceutical composition for the treatment or prevention of glomerulopathy | |
| IL112895A (en) | Pharmaceutical compositions for the treatment of obsessive-compulsive disorders comprising 5-HT2 antagonists | |
| HUP9903166A3 (en) | Medicinal compositions for the prophylaxis or treatment of arteriosclerosis | |
| PL316528A1 (en) | Pharmaceutic compositions and drugs for prevetion and treatment of endothelial disorders | |
| ZA983602B (en) | Use of tetrahydropyridine derivatives for the preparation of drugs for the treatment of diseases which cause demyelination | |
| HUP0200287A3 (en) | Pharmaceutical compositions for the treatment of neurological or neuropsychiatric disorders | |
| EP0747055A3 (en) | Use of tachykinin receptor antagonists to treat the common cold and allergic rhinitis | |
| HU0500865D0 (en) | Use of teophyllin derivatives for the preparation of pharmaceutical compositions for the prevention and treatment of shock | |
| EP0981357A4 (en) | METHODS AND COMPOSITIONS APPLICABLE TO THE DIAGNOSIS AND TREATMENT OF NEUROPSYCHIATRIC DISORDERS | |
| HUP9903688A3 (en) | Use of olanzapine for the preparation of pharmaceutical compositions treating autism | |
| AU686084B3 (en) | Pharmaceutical compositions for the treatment of depressive disorders | |
| IL120005A (en) | Pharmaceutical compositions for the treatment of the eye | |
| BR9507732A (pt) | Composição farmacêutica para o tratamento de glaucoma | |
| HUP9902737A3 (en) | The use of aryl-cyclohexylamine derivatives for preparing pharmaceutical compositions suitable for treatment of cns disorders | |
| AP9700928A0 (en) | Pharmaceutical compositions for the prevention or treatment of retrovirus infections |